Table 1

Description of BOKS, FOA and MOST participants

BOKS (224 knees from 224 subjects)FOA (1159 knees from 985 subjects)FOA (428 knees with measured alignment from 350 subjects)MOST (1621 knees from 1381 subjects)
Age, mean (SD), years66.7 (9.4)63.4 (8.8)65.0 (8.9)62.1 (8.0)
BMI, mean (SD), kg/m230.7 (4.8)28.6 (5.6)29.2 (5.5)30.0 (4.9)
Female, N (%)92 (41.1)564 (57.3)196 (56.0)843 (61.0)
Knee pain, N (%)200 (94.0)268 (23.7)124 (29.6)*537 (33.2)
Radiographic PF OA, N (%)142 (64.0)88 (7.8)67 (15.7)*288 (18.0)
PF JSN grade, N (%)
0109 (49.1)1085 (96.4)403 (94.6)*1396 (87.1)
168 (30.6)24 (2.1)12 (2.8)*84 (5.2)
2–2.530 (13.5)13 (1.2)8 (1.9)*80 (5.0)
33 (6.8)4 (0.4)3 (0.7)*43 (2.7)
TF KL grade, N (%)
017 (7.6)863 (76.4)220 (51.4)*667 (41.2)
140 (17.9)53 (4.7)19 (4.4)*301 (18.6)
251 (22.8)105 (9.3)98 (22.9)*316 (19.5)
370 (31.2)69 (6.1)59 (13.8)*276 (17.1)
3.5–446 (20.5)38 (3.4)32 (7.5)*59 (3.6)
TF alignment, N (%)
Varus140 (62.5)NA213 (49.8)777 (47.9)
Neutral48 (21.4)NA183 (42.8)532 (32.8)
Valgus36 (16.1)NA32 (7.5)312 (19.3)
  • In accordance with the Osteoarthritis Research Society International (OARSI) atlas, PF ROA was identified when a definite osteophyte (OARSI score >2) was visible at the PF joint, or when PF Joint Space Narrowing (JSN) (OARSI score >1) was present along with any PF osteophyte, sclerosis or cyst (OARSI score >1).

  • * Indicates a significant difference (p<0.05) between the entire FOA cohort and FOA participants with measured knee alignment, using crude linear regression, logistic regression and proportional odds models with adjustment for correlation between two knees of a subject.

  • BMI, body mass index; BOKS, Boston Osteoarthritis of the Knee Study; FOA, Framingham Osteoarthritis Study; KL, Kellgren and Lawrence; MOST, Multicenter Osteoarthritis Study; OA, osteoarthritis; PF, patellofemoral; TF, tibiofemoral.